Page 7 - Patient Groups News Today

An old juristic measure by the biden administration. —— altruistic measure. a controversial new treatment for alzheimers has been approved by regulators in the us. aducanumab targets the underlying cause of the disease rather than just easing symptoms. patient groups have campaigned for its approval, but it is a contentious decision. some experts and indeed the fdas independent advisory committee opposed its approval. 0ur medical editor, fergus walsh, reports. this is an historic moment in t...

The last several months. in conversations with the guatemalan president, i appreciate she is frank, she doesnt hold back and is willing to deal with these issues. that suggests a humility to speak truth to global counterparts will be important in foreign policy. it is going to be interesting. ed 0keefe, joining us from guatemala city. we apologise for the quality of the line. it was a bit scratchy, wasnt it, but i think we got the gist of what ed was saying. a controversial new treatment for alz...

Humanitarian aid, this $4 billion package over four years, one of the things bolstered will be security forces. security forces would be expected to disarm and tackle the international drug organisations and criminal organisations that run the drug routes north and the people trafficking routes north. but it would also be to stop, for example, the caravans of people weve seen trying to leave, who have been, you know, stopped from doing so with water cannon and tear gas and so on. you know, this ...

Alzheimers, but it is the first treatment to tackle the underlying mechanism which destroys brain function in this most cruel of conditions. and that alone makes this a landmark moment. the scientific reaction has been mixed, many welcoming this as a milestone, which will boost research. but others saying they believe this drug will only have marginal benefits. and it will take years yet to know just how good this drug is. patient groups here reckon that upwards of 100,000 people with early alzh...

This a landmark moment. thejury is still out on this drug. some doctors remain sceptical and us regulators have said everyone there who received it will need to be part of an ongoing trial and they have said they will pull approval in a few years if it fails to live up to the improvements in cognition the manufacturers are promising. here in the uk, patient groups reckon 100,000 people with early alzheimers could benefit and they will be pressing regulators for a decision here but that is likely...

It carries controversy. the drug reportedly costs about $56,000 per year, and several experts have advised against using it. lets bring in dr. rainy, an emergency physician at brown university and the co-founder of ge getusppe.org. this is confusing because last year an fda advisory committee concluded there wasnt enough evidence to support the effectiveness of this treatment, but then the fda went ahead and approved it, so why? >> it is a very confusing story. listen, there was one positive tri...

I feel very confident about where i am, and i feel very encouraged of the overwhelming support in my caucus that will go to the floor. >> 100%. a lot of people, including plenty of democrats say they do not want your mother to return as speaker of the house. why do you think they are wrong? >> well, because majority of the democrats do, and the fact of the matter is i spent the last couple of years in pashship with so many of our friends from patient groups and care giver groups and veterans gro...

Corker and ron johnson and any other republican senator who might peel off from what theyre trying to do here. tonight is steve mnuchin and bride hold money night. vote on the republican tax bill is tomorrow in the house. dont think about rich people. outside of republicans in congress and donors most important to them, this bill doesnt have a lot of friends. lots of different types of people have reasons to be strongly against this. for example, anybody with health insurance, anybody who only g...

People have an idea of what the world looks like. we govern well, we covered with compromise. if we dont do that, i think we will end up where we are essentially saying we dont like it, so lets just keep shooting at it and it will get worse and worse and worse for people. i dont think people expect them to govern, and i think we can take up in the new year long-term reforms of whatever type. theres no question that there are elements of every law that need to be working better. but right now, we...

Of access to pre -- if you have pre-existing conditions. >> if it passes the senate, if they get those 50 votes this week and the deadline is saturday september 30th after which they need 60 votes. that is the effective deadline. if they get the votes somehow persuade people to do it without having a real score from the cbo, what is the outlook in the house? >> well, lets fight one fight at a time. i think its really important as people are weighing in and again, the outside advocacy groups of p...